In previous genomic studies, glioma outcome and progression were shown to correlate with macrophage and microglia gene expression [3], while polymorphisms in the microglial CX3CR1 chemokine receptor locus were associated with improved patient survival [4]. The gene discussed is CX3CR1; the disease is glioma.